Etamsylate is administered intravenously, intramuscularly, in ophthalmology subconjunctival and retrobulbar. Etamsylate can be administered intravenously drip in a 5% solution of glucose or in an isotonic solution of sodium chloride.
Adults: for prophylactic purposes for surgical interventions, the drug is administered intravenously or intramuscularly 1 hour prior to surgery at a dose of 0.25-0.5 g (2-4 ml of 12.5% solution), if necessary during surgery - at a dose of 0.25 -0.5 g (2-4 ml of 12.5% solution), with the danger of postoperative bleeding - 0.5-0.75 g (4-6 ml of 12.5% solution) during the day.
Children: if necessary, intraoperatively Etamsylate is administered intravenously at a rate of 8-10 mg / kg body weight.
To stop bleeding Etamsylate Enter intravenously or intramuscularly 0.25-0.5 g (2-4 ml of 12.5% solution), after which every 4-6 hours to 0.25 g (2 ml of 12.5% solution) for 5-10 days.
When treating metro-menorrhagia Etamsylate appoint a single dose of 0.25 g (2 ml of 12.5% solution) intravenously or intramuscularly every 6-8 hours for 5-10 days.
With diabetic microangiopathy Etamsylate administered intramuscularly for 10-14 days in a single dose of 0.25-0.5 g three times a day
In ophthalmology Etamsylate injected subconjunctivally or retrobulbarno - in a dose of 0.125 g (1 ml of 12.5% solution).